Fate Therapeutics Reports Second Quarter 2014 Financial Results

Go back to Fate Therapeutics Reports Second Quarter 2014 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.51 +0.07 (2.87%)
Previous Close $2.44    52 Week High $4.76 
Open $2.48    52 Week Low $1.46 
Day High $2.56    P/E N/A 
Day Low $2.46    EPS $-1.91 
Volume 965,046